European Union

EPO Patent Application EP2026030647A1 for Molecules Controlling Allergic Diseases

The European Patent Office has published patent application EP2026030647A1 concerning molecules for controlling allergic diseases. The application was published on March 18, 2026, and lists various IPC classifications related to biotechnology and pharmaceuticals. The designation of inventors has not yet been filed.

EPO Patent: Cardiomyopathy Treatment With ATF4 Gene Therapy

The European Patent Office has published patent application EP2026030234A2 concerning a gene therapy for the prevention and treatment of cardiomyopathy-related diseases using ATF4. The publication date is March 18, 2026, and it covers designated states within the European Union.

EPO Patent Publication: Gene Therapy for Beta-Hemoglobinopathies

The European Patent Office has published a patent application (EP2026029716A1) concerning a polynucleotide construct for gene therapy of beta-hemoglobinopathies. The publication date is March 18, 2026, and it includes IPC classifications related to biotechnology and medical treatments.

TAQ DNA POLYMERASE MUTANT Patent Publication

The European Patent Office has published patent application EP2026030656A1 concerning a TAQ DNA POLYMERASE MUTANT. The publication date is March 18, 2026. The inventors have not yet filed their designation.

EPO Patent Publication: Bioengineered Bacteria for Biofilm Curation

The European Patent Office has published a new patent application, EP2026030202A1, concerning the use of bioengineered bacteria for curating biofilms. The publication date is March 18, 2026, and it covers various International Patent Classifications related to medical treatments and biotechnology.

EPO Patent Publication: Intestinal Organoid and Method for Producing Same

The European Patent Office (EPO) has published patent application EP2026029043A1 concerning an intestinal organoid and a method for its production. The publication date is March 18, 2026. The inventors have not yet been designated.

EPO Patent Publication: Engineered Producer Cell

The European Patent Office (EPO) has published a patent application (EP2026030520A1) related to engineered producer cells and methods for their production and use. The publication date is March 18, 2026, and it covers multiple designated states within the European Union.

Ionis Pharmaceuticals - Conjugated Antisense Compounds Patent

The European Patent Office has published patent application EP4711459A2 for Ionis Pharmaceuticals, detailing conjugated antisense compounds, specifically those conjugated to N-Acetylgalactosamine. This publication relates to advancements in oligonucleotide therapeutics and their potential applications.

EPO Patent Application EP2026030528A1 for Activated Hepatocyte Growth Factor

The European Patent Office (EPO) has published patent application EP2026030528A1 concerning activated hepatocyte growth factor. The publication date is March 18, 2026, and the inventors have not yet been designated.

Klotho mRNA Patent EP4711452A2 Published

The European Patent Office published patent application EP4711452A2 on March 18, 2026, related to Klotho messenger-RNA (mRNA) technology. The patent application was filed by ADvantage Therapeutics, Inc. and details specific compositions and sequences for Klotho polypeptides.